Benicar Litigation

Benicar is a popular type of medication used for treating high blood pressure (hypertension). It is a drug which stops blood vessels from narrowing, which lowers the patient’s blood pressure and increases blood flow. Manufactured by Daiichi Sankyo (Die-EE-chee SANK-yo) which is a global pharmaceutical holding company and the second largest drug company in Japan.

Side effects of Benicar

Some common side effects are:

  • Excessive weight loss
  • Chronic diarrhea
  • Vomiting
  • Dehydration
  • Malnutrition
  • Intestinal damage
  • Kidney failure
  • Other gastrointestinal (GI) side effects

It has been reported that the drug can cause a GI condition known as sprue-like enteropathy, which causes symptoms similar to those of celiac disease.

Misdiagnosis of Benicar Celiac Disease

Celiac disease symptoms include:

  • abdominal bloating and pain
  • chronic diarrhea
  • vomiting
  • constipation
  • pale, foul smelling or fatty stool
  • weight loss

Some patients will visit their physicians who may put them on a gluten free diet only to find that GI symptoms persist.

Benicar Update: First Enteropathy Cases will go to Trial Fall 2016

Lawsuits filed against Daiichi-Sankyo over sprue-like enteropathy side effects allegedly caused by Benicar may go to trial later in 2016 according to a U.S. District Judge in New Jersey.  Currently over 1,000 cases are on file; however, this number is expected to grow to as many as 4,000 before the litigation process is complete.  In April 2015, all federally-filed Benicar cases were centralized in a multidistrict litigation and transferred to the U.S. District Court, District of New Jersey.

Filing a Lawsuit

By filing a lawsuit against the maker of Benicar, you may be entitled to collect compensation for all current and future medical expenses related to the treatment of your GI disorder, as well as damages for pain and suffering. In addition, filing a lawsuit can help hold the drug’s maker accountable for releasing an allegedly defective drug into the marketplace and to discourage other pharmaceutical companies from engaging in similar conduct.

FDA Warns Benicar Use May Cause Enteropathy, GI Side Effects

The FDA announced Benicar (marketed as Benicar, Benicar HCT, Azor, Tribenzor, and in the generic form as olmesartan medoxomil) would receive a label update to reflect the risk of sprue-like enteropathy. According to the FDA’s drug safety communication, this GI disorder can cause symptoms that include severe, chronic diarrhea with substantial weight loss. The condition may take months or years to develop and may require hospitalization, the agency said. Click here for more information.

The link between Benicar and enteropathy was first uncovered in 2012. Researchers from the Mayo Clinic found that over a three-year period, 22 patients taking the drug displayed symptoms suggestive of celiac disease; however, blood tests for the patients did not support this diagnosis. When patients stopped taking the drug, their GI symptoms improved, according to one of the authors of the study. Several months later, researchers from the American College of Gastroenterology noted that olmesartan, the active ingredient in Benicar, had been linked to an additional 40 cases of sprue-like enteropathy.

If you or a loved one suffered from chronic diarrhea or substantial weight loss after being prescribed Benicar, only a qualified personal injury attorney can determine whether you are eligible to file a lawsuit seeking compensation for damages.  We are currently accepting Benicar induced injury cases in all 50 states.